4cmo: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 2-((1R)-1-((3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl) oxy)ethyl)-4-fluoro-N-methylbenzamide== | ==Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 2-((1R)-1-((3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl) oxy)ethyl)-4-fluoro-N-methylbenzamide== | ||
<StructureSection load='4cmo' size='340' side='right' caption='[[4cmo]], [[Resolution|resolution]] 2.05Å' scene=''> | <StructureSection load='4cmo' size='340' side='right'caption='[[4cmo]], [[Resolution|resolution]] 2.05Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4cmo]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CMO OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CMO FirstGlance]. <br> | <table><tr><td colspan='2'>[[4cmo]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CMO OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CMO FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=YPW:2-[(1R)-1-{[3-AMINO-6-(2-METHOXYPYRIDIN-3-YL)PYRAZIN-2-YL]OXY}ETHYL]-4-FLUORO-N-METHYLBENZAMIDE'>YPW</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=YPW:2-[(1R)-1-{[3-AMINO-6-(2-METHOXYPYRIDIN-3-YL)PYRAZIN-2-YL]OXY}ETHYL]-4-FLUORO-N-METHYLBENZAMIDE'>YPW</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cli|4cli]], [[4clj|4clj]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cli|4cli]], [[4clj|4clj]]</td></tr> | ||
| Line 22: | Line 22: | ||
</div> | </div> | ||
<div class="pdbe-citations 4cmo" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4cmo" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Tyrosine kinase|Tyrosine kinase]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | |||
[[Category: Large Structures]] | |||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
[[Category: Brooun, A]] | [[Category: Brooun, A]] | ||
